TRPS1
Basic information
Region (hg38): 8:115408496-115809673
Links
Phenotypes
GenCC
Source:
- trichorhinophalangeal syndrome type I (Definitive), mode of inheritance: AD
- trichorhinophalangeal syndrome type I or III (Supportive), mode of inheritance: AD
- trichorhinophalangeal syndrome, type III (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Trichorhinophalangeal syndrome, type I; Trichorhinophalangeal syndrome, type III | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 5991804; 10615131; 11112658; 19419465; 19610100; 19758263; 20394624; 21740822; 22481165 ; 27133561 |
ClinVar
This is a list of variants' phenotypes submitted to
- Trichorhinophalangeal_dysplasia_type_I (530 variants)
- Trichorhinophalangeal_syndrome,_type_III (474 variants)
- Inborn_genetic_diseases (154 variants)
- not_provided (120 variants)
- TRPS1-related_disorder (22 variants)
- not_specified (10 variants)
- Trichorhinophalangeal_syndrome (3 variants)
- Microcephaly (3 variants)
- Trichorhinophalangeal_syndrome_type_I_or_III (2 variants)
- Langer-Giedion_syndrome (2 variants)
- Craniosynostosis_syndrome (1 variants)
- Pear-shaped_nose (1 variants)
- Metaphyseal_chondrodysplasia (1 variants)
- Mitral_valve_prolapse (1 variants)
- Alopecia_areata (1 variants)
- Abnormally_high-pitched_voice (1 variants)
- Proportionate_short_stature (1 variants)
- Sparse_hair (1 variants)
- See_cases (1 variants)
- Sparse_and_thin_eyebrow (1 variants)
- Hyperextensible_skin (1 variants)
- Short_stature (1 variants)
- Congenital_anomaly_of_kidney_and_urinary_tract (1 variants)
- Brachydactyly (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRPS1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014112.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 111 | 15 | 129 | |||
missense | 14 | 308 | 67 | 404 | ||
nonsense | 47 | 56 | ||||
start loss | 0 | |||||
frameshift | 66 | 15 | 13 | 94 | ||
splice donor/acceptor (+/-2bp) | 10 | |||||
Total | 123 | 41 | 328 | 178 | 23 |
Highest pathogenic variant AF is 0.00000658389
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRPS1 | protein_coding | protein_coding | ENST00000395715 | 6 | 401176 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000102 | 124686 | 0 | 2 | 124688 | 0.00000802 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.54 | 562 | 675 | 0.833 | 0.0000373 | 8551 |
Missense in Polyphen | 229 | 342.13 | 0.66934 | 4372 | ||
Synonymous | -0.601 | 283 | 270 | 1.05 | 0.0000169 | 2490 |
Loss of Function | 5.92 | 1 | 42.9 | 0.0233 | 0.00000234 | 584 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000178 | 0.0000177 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional repressor. Binds specifically to GATA sequences and represses expression of GATA-regulated genes at selected sites and stages in vertebrate development. Regulates chondrocyte proliferation and differentiation. Executes multiple functions in proliferating chondrocytes, expanding the region of distal chondrocytes, activating proliferation in columnar cells and supporting the differentiation of columnar into hypertrophic chondrocytes. {ECO:0000269|PubMed:12885770, ECO:0000269|PubMed:17391059}.;
- Disease
- DISEASE: Tricho-rhino-phalangeal syndrome 1 (TRPS1) [MIM:190350]: Autosomal dominant disorder characterized by craniofacial and skeletal abnormalities. It is allelic with tricho-rhino-phalangeal type 3. Typical features include sparse scalp hair, a bulbous tip of the nose, protruding ears, a long flat philtrum and a thin upper vermilion border. Skeletal defects include cone-shaped epiphyses at the phalanges, hip malformations and short stature. {ECO:0000269|PubMed:14560312}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tricho-rhino-phalangeal syndrome 2 (TRPS2) [MIM:150230]: A syndrome that combines the clinical features of tricho-rhino- phalangeal syndrome type 1 and multiple exostoses type 1. Affected individuals manifest multiple dysmorphic facial features including large, laterally protruding ears, a bulbous nose, an elongated upper lip, as well as sparse scalp hair, winged scapulae, multiple cartilaginous exostoses, redundant skin, and mental retardation. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration resulting in the loss of functional copies of TRPS1 and EXT1 has been found in TRPS2 patients.; DISEASE: Tricho-rhino-phalangeal syndrome 3 (TRPS3) [MIM:190351]: Autosomal dominant disorder characterized by craniofacial and skeletal abnormalities. It is allelic with tricho-rhino-phalangeal type 1. In TRPS3 a more severe brachydactyly and growth retardation are observed. {ECO:0000269|PubMed:11112658, ECO:0000269|PubMed:11807863}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.0223
- rvis_EVS
- -1.75
- rvis_percentile_EVS
- 2.36
Haploinsufficiency Scores
- pHI
- 0.668
- hipred
- Y
- hipred_score
- 0.696
- ghis
- 0.533
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.257
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trps1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; skeleton phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;skeletal system development;transcription by RNA polymerase II;NLS-bearing protein import into nucleus;regulation of chondrocyte differentiation;protein heterooligomerization
- Cellular component
- nuclear chromatin;nucleus;nucleoplasm;protein-containing complex
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;zinc ion binding;protein domain specific binding